Clinical Trial Update: Effects of SAMe in Patients With Alcoholic Liver Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SAMe (S-adenosyl-L-methionine) in patients with alcoholic liver disease has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease

Drugs mentioned

• SAMe (S-adenosyl-L-methionine) (S-adenosyl-L-methionine)

Snippet

Sponsor: University of California, Davis | Conditions: Liver Disease, Alcoholic | Phase 3 | Status: COMPLETED | Results posted: 2013-06-10